Ivana Magovcevic-Liebisch
Independent DirectorDr. Ivana Magovcevic-Liebisch, Ph. D., J. D., is Independent Director of Almirall, S.A. from June 2026. She is Independent Director of Quanterix Corporation from October 2, 2024. Dr. Magovcevic-Liebisch is Independent Director of Acrivon Therapeutics, Inc. from February 08, 2024. Dr. Magovcevic-Liebisch is President & CEO of Draig Therapeutics Ltd from November 2025. Dr. Magovcevic-Liebisch was Strategic Advisor of Jefferson Life Sciences. Dr. Magovcevic-Liebisch was Atlas Advisor of Atlas Venture Advisors, Inc. from December 2024 to 2026. Dr. Magovcevic-Liebisch was employed at Atlas Venture Advisors, Inc. until 2026. Dr. Magovcevic-Liebisch was Executive VP & Chief Business Officer of Ipsen S.A. from March 13, 2018 to 2020. Dr. Magovcevic-Liebisch was employed at Ipsen S.A. from March 13, 2018 to 2020. Dr. Magovcevic-Liebisch was Chief Operating Officer and Executive Vice President of Dyax Corp. Dr. Magovcevic-Liebisch was employed at Dyax Corp. from February 2004 to March 29, 2013. Dr. Magovcevic-Liebisch was Head of Corporate Business Development and Senior Vice President of Teva Pharmaceutical Industries Limited. Dr. Magovcevic-Liebisch joined the Teva Pharmaceutical Industries Limited in April 2013. Dr. Magovcevic-Liebisch was Independent Director of Beacon Therapeutics (USA), Inc. from June 2014 to March 09, 2022. Dr. Magovcevic-Liebisch was employed at Beacon Therapeutics (USA), Inc. from June 30, 2014 to March 09, 2022. Dr. Magovcevic-Liebisch was Independent Director of Spyre Therapeutics, Inc. from March 22, 2018 to November 22, 2023. Dr. Magovcevic-Liebisch was employed at Spyre Therapeutics, Inc. from March 22, 2018 to November 22, 2023. Dr. Magovcevic-Liebisch was Advisor of PureTech Health plc. Dr. Magovcevic-Liebisch was employed at PureTech Health plc from October 13, 2016 to April 06, 2017. Dr. Magovcevic-Liebisch was Chief Strategy & Corporate Development Officer and Executive VP of Axcella Health Inc. until March 2018. Dr. Magovcevic-Liebisch, Ph. D., J. D., was employed at Axcella Health Inc. from May 11, 2017 to March 2018. Dr. Magovcevic-Liebisch was Independent Chairperson of Absci Corporation from January 2021 to June 14, 2023. Dr. Magovcevic-Liebisch was Director of Absci Corporation from August 2020. Dr. Magovcevic-Liebisch was employed at Absci Corporation until June 14, 2023. Dr. Magovcevic-Liebisch was Industry Advisor of Agent Capital, LLC. Dr. Magovcevic-Liebisch was President, CEO & Director of Vigil Neuroscience, Inc. from July 2020 to August 2025. Dr. Magovcevic-Liebisch was employed at Vigil Neuroscience, Inc. until August 2025. Dr. Magovcevic-Liebisch has Ph.D. in Genetics from Harvard University in 1994, B.A. in Biology & Chemistry from Wheaton College (Massachusetts) in 1989, J.D. in Technology from Suffolk University Law School in 1999.
Positions
- Company NameQuanterix CorporationStock CodeQTRXPositionIndependent DirectorColleagues
- WPWilliam P. DonnellyExecutive Chair
- DRDavid R. WaltCo-Founder & Chairman of Scientific Advisory Board
- JGJames GuteChief Commercial Officer, Interim President & Interim CEO
- JGJames GuteChief Commercial Officer, Interim CEO & Interim President
- JFJason FaesslerCFO & Treasurer
- KAKaren A. FlynnIndependent Director
- JTJeffrey T. ElliottLead Independent Director
